Abstract
Fryns syndrome (FS) is a multiple malformations syndrome with major features of congenital diaphragmatic hernia, pulmonary hypoplasia, craniofacial dysmorphic features, distal digit hypoplasia, and a range of other lower frequency malformations. FS is typically lethal in the fetal or neonatal period. Inheritance is presumed autosomal recessive. Although no major genetic cause has been identified for FS, biallelic truncating variants in PIGN, encoding a component of the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, have been identified in a limited number of cases with a phenotype compatible with FS. Biallelic variants in PIGN, typically missense or compound missense with truncating, also cause multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1). Here we report six further patients with FS with or without congenital diaphragmatic hernia and recessive loss of function PIGN alleles, including an intragenic deletion with a likely founder effect in La Réunion and other Indian Ocean islands. Our results support the hypothesis that a spectrum of phenotypic severity is associated with recessive PIGN variants, ranging from FS at the extreme end, caused by complete loss of function, to MCAHS1, in which some residual PIGN function may remain. Our data add FS resulting from PIGN variants to the catalog of inherited GPI deficiencies caused by the disruption of the GPI-anchor biosynthesis pathway.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Fryns JP. A variable MCA syndrome with diaphragmatic defects, coarse face, and distal limb hypoplasia. J Med Genet. 1987;24:271–4.
Slavotinek AM. Fryns syndrome: a review of the phenotype and diagnosis guidelines. Am J Med Genet. 2004;124A:427–33.
Lin AE, Pober BR, Mullen MP, Slavotinek AM. Cardiovascular malformations in Fryns syndrome: is there a pathogenic role for neural crest cells? Am J Med Genet A. 2005;139:186–93.
Slavotinek A, Lee SS, Davis R, et al. Fryns syndrome phenotype caused by chromosome microdeletions at 15q26.2 and 8p23.1. J Med Genet. 2005;42:730–6.
Bone KM, Chernos JE, Perrier R, et al. Mosaic trisomy 1q: a recurring chromosome anomaly that is a diagnosis challenge and is associated with a Fryns-like phenotype. Prenat Diag. 2017;37:602–10.
Brady PD, Moerman P, De Catte L, Deprest J, Devriendt K, Vermeesch JR. Exome sequencing identifies a recessive PIGN splice mutation as a cause of syndromic congenital diaphragmatic hernia. Eur J Med Genet. 2014;57:487–93.
McInerney-Leo AM, Harris JE, Gattas M, et al. Fryns syndrome associated with recessive mutations in PIGN in two separate families. Hum Mutat. 2016;37:695–702.
Alessandri JL, Cuillier F, Malan V, et al. Fryns syndrome without diaphragmatic hernia, DOOR syndrome or Fryns-like syndrome? Report on patients from Indian Ocean islands. Am J Med Genet. 2014;164A:648–54.
Thevenon J, Duffourd Y, Masurel-Paulet A, et al. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test. Clin Genet. 2016;89:700–7.
Poultney CS, Goldberg AP, Drapeau E, et al. Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder. Am J Hum Mut. 2013;93:607–19.
Gordon CT, Petit F, Kroisel PM, et al. Mutations in endothelin 1 cause recessive auriculocondylar syndrome and dominant isolated question-mark ears. Am J Hum Genet. 2013;93:1118–25.
Kinoshita T. Biosynthesis and deficiencies of glycosylphosphatidylinositol. Proc Jpn Acad Ser B Phys Biol Sci. 2014;90:130–43.
Johnstone DL, Nguyen TTM, Murakami Y, et al. Compound heterozygous mutations in the gene PIGP are associated with early infantile epileptic encephalopathy. Hum Mol Genet. 2017;26:1706–15.
Maydan G, Noyman I, Har-Zahav A, et al. Multiple congenital anomalies-hypotonia-seizures syndrome is caused by a mutation in PIGN. J Med Genet. 2011;48:383–9.
Couser NL, Masood MM, Strande NT, et al. The phenotype of multiple congenital anomalies-hypotonia-seizures syndrome 1: report and review. Am J Med Genet. 2015;167A:2176–81.
Fleming L, Lemmon M, Beck N, et al. Genotype–phenotype correlation of congenital anomalies in multiple congenital anomalies hypotonia seizures syndrome (MCAHS1)/PIGN-related epilepsy. Am J Med Genet. 2016;170A:77–86.
Khayat M, Tilghman JM, Chervinsky I, Zalman L, Chakravarti A, Shalev SA. A PIGN mutation responsible for multiple congenital anomalies-hypotonia-seizures syndrome 1 (MCAHS1) in an Israeli-Arab family. Am J Med Genet. 2016;170A:176–82.
Nakagawa T, Taniguchi-Ikeda M, Murakami Y, et al. A novel PIGN mutation and prenatal diagnosis of inherited glycosylphosphatidylinositol deficiency. Am J Med Genet. 2016;170A:183–8.
Ohba C, Okamoto N, Murakami Y, et al. PIGN mutations cause congenital anomalies, developmental delay, hypotonia, epilepsy, and progressive cerebellar atrophy. Neurogenetics. 2014;15:85–92.
Jezela-Stanek A, Ciara E, Piekutowska-Abramczuk D, et al. Congenital disorder of glycosylphosphatidylinositol (GPI)-anchor biosynthesis—the phenotype of two patients with novel mutations in the PIGN and PGAP2 genes. Eur J Paediat Neurol. 2016;20:462–73.
James AW, Miranda SG, Culver K, Hall BD, Golabi M. DOOR syndrome: clinical report, literature review and discussion of natural history. Am J Med Genet. 2007;143A:2821–31.
Campeau PM, Kasperaviciute D, Lu JT, et al. The genetic basis of DOORS syndrome: an exome-sequencing study. Lancet Neurol. 2014;13:44–58.
Van Hove JL, Spiridigliozzi GA, Heinz R, McConkie-Rosell A, Iafolla AK, Kahler SG. Fryns syndrome survivors and neurologic outcome. Am J Med Genet. 2002;59:334–40.
Dentici ML, Brancati F, Mingarelli R, Dallapiccola B. A 6-year-old child with Fryns syndrome: further delineation of the natural history of the conditions in survivors. Eur J Med Genet. 2009;52:421–5.
Riela AR, Thomas LT, Gonzales AR, Ifft RD. Fryns syndrome: neurologic findings in a survivor. J Child Neurol. 1995;10:110–3.
Cole DE, Thompson MD. Neurogenetic aspects of hyperphosphatasia in Mabry syndrome. Subcell Biochem. 2015;76:343–61.
Thompson MD, Cole DE. Recessive PIGN mutations in Fryns syndrome: evidence for genetic heterogeneity. Hum Mut. 2016;37:621.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Jean-Luc Alessandri and Christopher T. Gordon contributed equally to this work.
Rights and permissions
About this article
Cite this article
Alessandri, JL., Gordon, C.T., Jacquemont, ML. et al. Recessive loss of function PIGN alleles, including an intragenic deletion with founder effect in La Réunion Island, in patients with Fryns syndrome. Eur J Hum Genet 26, 340–349 (2018). https://doi.org/10.1038/s41431-017-0087-x
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41431-017-0087-x
This article is cited by
-
PIGF deficiency causes a phenotype overlapping with DOORS syndrome
Human Genetics (2021)
-
Analyzing clinical and genetic characteristics of a cohort with multiple congenital anomalies-hypotonia-seizures syndrome (MCAHS)
Orphanet Journal of Rare Diseases (2020)
-
The Glycosylphosphatidylinositol biosynthesis pathway in human diseases
Orphanet Journal of Rare Diseases (2020)
